临床试验

Nitrous Oxide For Endoscopic Ablation of Refractory Barrett's Esophagus (NO FEAR-BE)

NCT：NCT03554356 · ACTIVE_NOT_RECRUITING

NCT编号NCT03554356

状态ACTIVE_NOT_RECRUITING

开始日期2018-09-04

SponsorUniversity of North Carolina, Chapel Hill (OTHER)

First posted2018-06-13

Last updated2026-09-14

简要摘要

A multicenter, prospective, single arm, non randomized clinical trial to evaluate the safety and efficacy of the C2 CryoBalloon Focal Ablation System (CbFAS) for the treatment of persistent dysplasia or intestinal metaplasia (IM) in the tubular esophagus after 3 or more radiofrequency ablations (RFA) for dysplastic BE, or \<50% eradication of Barrett's Esophagus (BE) after 2 RFA treatments.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态，请参阅官方记录。